Publicly-traded company Arcadia Biosciences Inc. (NASDAQ:RKDA) had a closing price of $6.10 yesterday. Meanwhile, the average 12-month price target from Wall Street analysts is currently $15.00, this means that the stock is underpriced by 59.33%. In the past 52 weeks the company’s stock price has moved within the range of $1.82 to $10.40.
This particular stock’s 5-day moving average is 5.12, its 20-day moving average is 4.95 and its 100-day moving average is 4.68. Arcadia Biosciences Inc. (RKDA) currently has 8.67M shares outstanding, which means that its market capitalization is $52.89M.
The Details: Arcadia Biosciences Inc. (RKDA) Financial Health
We can also find the company’s Return on Assets, which is a percentage that shows us how well a company uses its current assets to make a profit. The larger the score, the better. At the moment, Arcadia Biosciences Inc. Return on Assets is -18.60%.
What Does Wall Street Say about Company?
When considering a stock buy, many investors seek to know what Wall Street analysts are saying about the company – by looking at the average analyst rating, for example. At the moment, the average analyst rating for RKDA is Buy. Out of 2 total analysts who were surveyed, 0 rated it a sell, 0 rated it a underweight, 0 rated it an overweight, 0 rated it hold, and 2 rated it a Buy.
Understanding Profitability at Arcadia Biosciences Inc. (RKDA)
A smart way of assessing a company’s profitability is by checking out its latest Earnings per Share (EPS). In the most recent financial results released by Arcadia Biosciences Inc., for the quarter ending on 09/2019, the company posted EPS of -0.80. The average estimate of Wall Street analysts had projected -0.78.
Wall Street analysts, on average, are forecasting the company’s EPS to be -0.77, compared to 0.93 reported in the same quarter last year. When it comes to net revenue, the average estimate from a total of 3 analysts is 290k – compared to 370k posted in the year-ago period.